High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib
Manuela Gambella1, Alberto Rocci, Roberto Passera
1appalumbo@yahoo.com.
Haematologica
|February 6, 2014
Abstract
No abstract available in PubMed .
More Related Videos
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
12.5K
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
8.6K
